摘要
目的探讨经直肠超声引导前列腺穿刺活检的临床应用价值。方法 2011年1月至2012年1月,我科60例选患者在无麻醉情况下,采用经直肠超声引导10点前列腺穿刺活检,取出前列腺组织送病理检查。结果 60例患者中,前列腺癌检出率为53.3%。前列腺特异性抗原(PSA)水平的不同,前列腺结节超声显示率差异具有统计学意义(P=0.0246),前列腺结节显示率随PSA水平的增加而增加(P=0.0014);不同PSA水平组的病理结果差异具有统计学意义(P<0.0001),穿刺阳性率随PSA水平升高而逐渐上升。结论超声结节检出率会随着PSA水平升高而增大,前列腺癌的检出率均与PSA水平呈正相关。经直肠引导前列腺穿刺法阳性率较高,安全性好,具有很高的临床推广价值。
Objective To evaluate the clinical value of transrectal ultrasound-guided prostate biopsy. Methods Sixty patients underwent 10 core prostate biopsy guided by transrectal ultrasound（TRUS） from January 2011 to January 2012.Results In 60 patients,the detection rate of prostate cancer were 53.3% （32/60）. The display rates of prostate nodule by TRUS increased with the rising of prostate-specific antigen（PSA） levels（Z=-2. 9971, P=0. 0014）. There was significantly different in display rates of prostate nodule of different PSA levels（x2= 9. 3854, P= 0. 0246） ;The positive rates of biopsy increased gradually with the rising of PSA levels（Z =- 4. 3657, P（ 0. 0001）. There was significantly different in the pathological results of different groups （x2. 1727, P 0. 0001）. Conclusion The display of prostate nodule by TRUS increases with the rising of PSA levels. The detec- tion rates of prostate cancer are positively correlated with PSA levels. The transrectal ultrasound-guided prostate biopsy has many advantages,such as more safety and less side effects, which will be valuable to the clinic.
出处
《济宁医学院学报》
2013年第2期121-123,共3页
Journal of Jining Medical University
关键词
经直肠超声
前列腺癌
前列腺穿刺
前列腺特异性抗原
Transrectal ultrasound
Prostate cancer
Prostate biopsy
Prostate specific antigen
